Digital repository of Slovenian research organisations

Show document
A+ | A- | Help | SLO | ENG

Title:Febrile illness in high-risk children : a prospective, international observational study
Authors:ID Van der Velden, Fabian Johannes Stanislaus (Author)
ID De Vries, Gabriella (Author)
ID Martin, Alexander James (Author)
ID Lim, Emma (Author)
ID Von Both, Ulrich (Author)
ID Kolberg, Laura (Author)
ID Carrol, Enitan D (Author)
ID Khanijau, Aakash (Author)
ID Pokorn, Marko (Author)
ID Kolnik, Mojca (Research coworker)
ID Vincek, Katarina (Research coworker)
ID Plankar Srovin, Tina (Research coworker)
ID Bahovec, Natalija (Research coworker)
ID Prunk, Petra (Research coworker)
ID Osterman, Veronika (Research coworker)
ID Avramoska, Tanja (Research coworker), et al.
Files:.pdf PDF - Presentation file, download (1,50 MB)
MD5: D4E59D1843BCA8A323F58B40A4318D67
 
URL URL - Source URL, visit https://link.springer.com/article/10.1007/s00431-022-04642-1
 
Language:English
Typology:1.01 - Original Scientific Article
Organization:Logo UKC LJ - Ljubljana University Medical Centre
Abstract:To assess and describe the aetiology and management of febrile illness in children with primary or acquired immunodeficiency at high risk of serious bacterial infection, as seen in emergency departments in tertiary hospitals. Prospective data on demographics, presenting features, investigations, microbiology, management, and outcome of patients within the 'Biomarker Validation in HR patients' database in PERFORM, were analysed. Immunocompromised children (< 18 years old) presented to fifteen European hospitals in nine countries, and one Gambian hospital, with fever or suspected infection and clinical indication for blood investigations. Febrile episodes were assigned clinical phenotypes using the validated PERFORM algorithm. Logistic regression was used to assess the effect size of predictive features of proven/presumed bacterial or viral infection. A total of 599 episodes in 482 children were analysed. Seventy-eight episodes (13.0%) were definite bacterial, 67 episodes probable bacterial (11.2%), and 29 bacterial syndrome (4.8%). Fifty-five were definite viral (9.2%), 49 probable viral (8.2%), and 23 viral syndrome (3.8%). One hundred ninety were unknown bacterial or viral infections (31.7%), and 108 had inflammatory or other non-infectious causes of fever (18.1%). Predictive features of proven/presumed bacterial infection were ill appearance (OR 3.1 (95% CI 2.1-4.6)) and HIV (OR 10.4 (95% CI 2.0-54.4)). Ill appearance reduced the odds of having a proven/presumed viral infection (OR 0.5 ( 95% CI 0.3-0.9)). A total of 82.1% had new empirical antibiotics started on admission (N = 492); 94.3% proven/presumed bacterial (N = 164), 66.1% proven/presumed viral (N = 84), and 93.2% unknown bacterial or viral infections (N = 177). Mortality was 1.9% (N = 11) and 87.1% made full recovery (N = 522). Conclusion: The aetiology of febrile illness in immunocompromised children is diverse. In one-third of cases, no cause for the fever will be identified. Justification for standard intravenous antibiotic treatment for every febrile immunocompromised child is debatable, yet effective. Better clinical decision-making tools and new biomarkers are needed for this population.
Keywords:immunocompromised, paediatric, children, fever, infection, antibiotics
Publication status:Published
Publication version:Version of Record
Year of publishing:2023
Number of pages:str. 543-554
Numbering:Vol. 182, issue 2
PID:20.500.12556/DiRROS-24231 New window
UDC:616-053.2
ISSN on article:1432-1076
DOI:10.1007/s00431-022-04642-1 New window
COBISS.SI-ID:243517955 New window
Note:Nasl. z nasl. zaslona; Opis vira z dne 23. 7. 2025;
Publication date in DiRROS:21.11.2025
Views:146
Downloads:63
Metadata:XML DC-XML DC-RDF
:
Copy citation
  
Share:Bookmark and Share


Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Record is a part of a journal

Title:European journal of pediatrics
Shortened title:Eur. j. pediatr.
Publisher:Springer
ISSN:1432-1076
COBISS.SI-ID:513665561 New window

Document is financed by a project

Funder:EC - European Commission
Project number:668303
Name:Personalised Risk assessment in febrile illness to Optimise Real-life Management across the European Union
Acronym:PERFORM

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.

Back